CMET-26. DIAGNOSTIC VALUE OF FDG-PET/CT FOR PATIENTS WITH BRAIN METASTASIS FROM UNKNOWN PRIMARY SITE

OBJECTIVE: In 30% of patients with brain metastasis (BM), BM are the first clinical manifestation of systemic malignancy, referred to as BM from cancer of unknown primary site (BM-CUPS). The value of 18F-fluordesoxyglucose positron emission tomography (FDG-PET)/CT in the work-up of BM-CUPS patients...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Wolpert, Fabian, Weller, Michael, Berghoff, Anna Sophie, Rushing, Elisabeth Jane, Füreder, Lisa Michaela, Petyt, Gregory, Leske, Henning, Andratschke, Nicolaus, Regli, Luca, Neidert, Marian Christoph, Stupp, Roger, Stahel, Rolf, Dummer, Reinhard, Frauenfelder, Thomas, Roth, Patrick, Reyns, Nicolas, Kaufmann, Philipp Antonio, Rhun, Emilie Le
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692907/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados